June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Manhattan Vision Screening and Follow-up Study (NYC-SIGHT) Cluster-Randomized Clinical Trial: Subanalysis of Telemedicine Retinal Findings
Author Affiliations & Notes
  • Desiree R. Henriquez
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Jason D. Horowitz
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Rabia Karani
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Jennifer O. Adeghate
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Prakash Gorroochurn
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Lisa Park
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Qing Wang
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Daniel Diamond
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Noga Harizman
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • James D. Auran
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Stefania C Maruri
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Jeffrey M Liebmann
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • George A Cioffi
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Tarun Sharma
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Lisa A. Hark
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Footnotes
    Commercial Relationships   Desiree Henriquez None; Jason Horowitz None; Rabia Karani None; Jennifer Adeghate None; Prakash Gorroochurn None; Lisa Park None; Qing Wang None; Daniel Diamond None; Noga Harizman None; James Auran None; Stefania Maruri None; Jeffrey Liebmann None; George Cioffi None; Tarun Sharma None; Lisa Hark None
  • Footnotes
    Support  US Centers for Disease Control and Prevention, U01 DP006435 and U01 DP006436 and Research to Prevention Blindness.
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 4182. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Desiree R. Henriquez, Jason D. Horowitz, Rabia Karani, Jennifer O. Adeghate, Prakash Gorroochurn, Lisa Park, Qing Wang, Daniel Diamond, Noga Harizman, James D. Auran, Stefania C Maruri, Jeffrey M Liebmann, George A Cioffi, Tarun Sharma, Lisa A. Hark; Manhattan Vision Screening and Follow-up Study (NYC-SIGHT) Cluster-Randomized Clinical Trial: Subanalysis of Telemedicine Retinal Findings. Invest. Ophthalmol. Vis. Sci. 2023;64(8):4182.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To describe abnormal retinal findings from the Manhattan Vision Screening and Follow-up Study, which aims to investigate whether innovative community-based eye health screening using telemedicine can improve early detection and management of retinal and other eye diseases among high-risk populations in New York City.

Methods : A 5-year prospective, cluster-randomized clinical trial. Eligible individuals (≥40 years) were recruited from affordable housing buildings and senior centers (≥60 years) in New York City. Participants underwent eye health screening in community settings (visual acuity (Snellen), intraocular pressure measurements (IOP), and fundus photography). Fundus images were remotely graded by both retina and glaucoma specialists, and those with an abnormal image were referred to ophthalmology for further evaluation. Those who failed the vision screening (visual acuity 20/40 or worse, IOP 23-29 mmHg, or had an unreadable image) were examined by the study optometrist in the community setting. Multivariate logistic regression analysis determined factors associated with odds of referral to ophthalmology for abnormal retinal findings.

Results : A total of 708 participants completed the eye health screening from 3/1/21 to 5/31/22; 157 had an abnormal retinal image and were referred to ophthalmology. These participants were predominantly older adults, (mean age 68.4±11.1 years), female (63.7%), African American (50.3%), and Hispanic (43.3%). Most individuals with a retinal abnormality (n=125, 79.6%) failed the eye health screening. Participants who self-identified as having pre-existing glaucoma [OR=3.750, 95% CI=(1.741, 8.074), p=0.0001] or had severe vision impairment defined as visual acuity 20/200 or worse [OR=1.185, 95% CI=(0.678, 2.066), p=0.000] had significantly higher odds of an abnormal retinal image.

Conclusions : This community-based study targeted populations at high-risk for eye disease, improved access to eye care, and utilized telemedicine, which detected a significant amount of retinal abnormalities requiring referral to ophthalmology. This has been made possible by advances in imaging technology and interpretation of acquired fundus photographs. The results provide insight into the burden of retinal diseases in this underserved population.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×